TCCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study January 02, 2015Vol.37 No.12
Conversation with The Cancer Letter Is Republican Control Better Than Two-Party Stalemate? December 19, 2014Vol.40 No.47By Matthew Bin Han Ong
Research Advocates Prepare to Face Republican-led Congress December 19, 2014Vol.40 No.47By Matthew Bin Han Ong
ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position December 19, 2014Vol.40 No.47By Paul Goldberg
Congress Plans to Accelerate Development of Drugs, Devices December 19, 2014Vol.40 No.47By Matthew Bin Han Ong
